Impact of controlled normothermia following hypothermic targeted temperature management for post-rewarming fever and outcomes in post-cardiac arrest patients: A propensity score-matched analysis from a multicentre registry. (May 2021)

• Record Type: Journal Article
• Authors: Kim, Kiwook; Lee, Byung Kook; Park, Jung Soo; Choi, Seung Phil; Jang, Tae Chang; Oh, Joo Suk
• Is Part Of: Resuscitation. Volume 162(2021)
• Page Start: 284
• Page End: 291
• Publication Date: 2021-05
• Subjects: Out-of-hospital cardiac arrest -- Targeted temperature management -- Controlled normothermia; Resuscitation -- Periodicals; Resuscitation -- Periodicals; Réanimation -- Périodiques; Electronic journals; 616.025
• DOI: 10.1016/j.resuscitation.2021.03.006
• Languages: English
• ISSNs: 0300-9572

Abstract

Abstract: Aim of the study: We investigated whether controlled normothermia (CN) after the rewarming phase of targeted temperature management (TTM) is associated with preventing post-rewarming fever and outcomes 6 months after out-of-hospital cardiac arrest (OHCA). Methods: This was an analysis of a prospective registry comprising OHCA patients treated with TTM at 22 academic hospitals between October 2015 and December 2018. We calculated the incremental area under the curve (iAUC) for body temperature greater than or equal to 37.5 °C for each patient during the first 24 h after the end of rewarming. The relationships among CN and iAUC, 6-month survival and good neurological outcome were analysed. To minimize differences in the baseline characteristics of the patients, we used propensity score-matched analysis. Results: In total, 1144 patients were enrolled. After propensity score matching, 646 patients (comprising 323 pairs) were obtained. In the unmatched cohort, post-rewarming CN was significantly associated with a lower iAUC (0.34 [1.38] vs. 1.19 [2.27]; p < 0.001) but not 6-month survival (adjusted odds ratio (OR): 1.121; 95% confidence interval (CI): 0.836−1.504; p = 0.446) and good neurological outcome (adjusted OR: 1.030; 95% CI: 0.734−1.446; p = 0.863). The results were similar in the propensity score-matched cohort (0.38 [1.56] vs. 1.03 [2.21], p < 0.001, OR: 1.347, 95% CI: 0.989−1.835, p = 0.059 and OR: 1.280, 95% CI 0.925−1.772, p = 0.137, respectively). Conclusion: Post-rewarming CN prevents high fever in the normothermia phase of TTM. However, our data suggest the lack of association between CN and the patient's 6-month survival and good neurological outcome.